Zura Bio Ltd (ZURA)
Zura Bio Limited is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to pioneering new therapeutic solutions for immune system and inflammatory diseases. Its key product candidates include ZB-168, an anti-IL7Rα inhibitor engineered to address conditions influenced by the IL7 and TSLP biological pathways. The company is also advancing Torudokimab, a monoclonal antibody that neutralizes IL-33, which is currently in Phase 2 clinical development.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Biotechnology
Zura Bio Limited
- Not computed: short interest % needs a single float figure, and the float on record is a bound or estimate.
- 8.5M
- 1.79
The cost to borrow ZURA shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.
- 24.9%
- 24
Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.
Latest short interest settlements (today's share basis)
| Date | Shares short |
|---|---|
| Oct 30, 2026 | 8.5M sh |
| Oct 15, 2026 | 7.0M sh |
| Sep 30, 2026 | 9.4M sh |
| Sep 15, 2026 | 9.3M sh |
| Aug 31, 2026 | 11.1M sh |
Latest fails to deliver
| Date | Shares failed |
|---|---|
| Oct 23, 2026 | 24 sh |
| Oct 13, 2026 | 2.6K sh |
| Sep 21, 2026 | 9.2K sh |
| Sep 10, 2026 | 18.3K sh |
| Aug 5, 2026 | 4 sh |
The three panels share one date axis, so a point's position is its date; each has its own value axis. Short interest is plotted on today's share basis, so the line does not step where a split does.
Latest sessions
| Date | Reported short |
|---|---|
| Nov 16, 2026 | 24.9% |
| Nov 13, 2026 | 8.4% |
| Nov 12, 2026 | 18.3% |
| Nov 11, 2026 | 23.5% |
| Nov 10, 2026 | 17.2% |
130 calendar days requested; 91 sessions published. FINRA reports this at T+1 to T+2, so the latest session is not today's.
Source: FINRA Reg SHO daily short volume, summed across the NASDAQ, NYSE and Consolidated trade reporting facilities. Covers off-exchange (over-the-counter) executions only; volume executed on an exchange is not included and is not reported short here.
Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.
FINRA's weekly alternative trading system (dark pool) volume for ZURA: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.
As of the Oct 30, 2026 FINRA settlement, 8,471,655 ZURA shares were sold short (1.79 days to cover).